These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Suppression of Kaposi's Sarcoma-Associated Herpesvirus Infection and Replication by 5'-AMP-Activated Protein Kinase. Cheng F; He M; Jung JU; Lu C; Gao SJ J Virol; 2016 Jul; 90(14):6515-6525. PubMed ID: 27147746 [TBL] [Abstract][Full Text] [Related]
5. Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication. Sanchez EL; Pulliam TH; Dimaio TA; Thalhofer AB; Delgado T; Lagunoff M J Virol; 2017 May; 91(10):. PubMed ID: 28275189 [TBL] [Abstract][Full Text] [Related]
6. Identification of new antiviral agents against Kaposi's sarcoma-associated herpesvirus (KSHV) by high-throughput drug screening reveals the role of histamine-related signaling in promoting viral lytic reactivation. Chen J; Dai L; Goldstein A; Zhang H; Tang W; Forrest JC; Post SR; Chen X; Qin Z PLoS Pathog; 2019 Dec; 15(12):e1008156. PubMed ID: 31790497 [TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential. Wakeman BS; Izumiya Y; Speck SH J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414 [TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus: the role of lytic replication in targeted therapy. Andrei G; Snoeck R Curr Opin Infect Dis; 2015 Dec; 28(6):611-24. PubMed ID: 26524334 [TBL] [Abstract][Full Text] [Related]
9. Discovery of a small-molecule inhibitor of KSHV lytic replication from the MMV pandemic response box. Okpara MO; Weaver F; Whitehouse A; Veale CGL; Edkins AL Antiviral Res; 2024 Oct; 230():105990. PubMed ID: 39154751 [TBL] [Abstract][Full Text] [Related]
10. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma. Klass CM; Offermann MK Curr Opin Oncol; 2005 Sep; 17(5):447-55. PubMed ID: 16093794 [TBL] [Abstract][Full Text] [Related]
11. In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus. Medveczky MM; Horvath E; Lund T; Medveczky PG AIDS; 1997 Sep; 11(11):1327-32. PubMed ID: 9302441 [TBL] [Abstract][Full Text] [Related]
12. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication. Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712 [TBL] [Abstract][Full Text] [Related]
14. [Replication Machinery of Kaposi's Sarcoma-associated Herpesvirus and Drug Discovery Research]. Watanabe T; Fujimuro M Yakugaku Zasshi; 2019; 139(1):69-73. PubMed ID: 30606932 [TBL] [Abstract][Full Text] [Related]
15. Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Interferes with mTORC1 Regulation of Autophagy and Viral Protein Synthesis. Pringle ES; Robinson CA; McCormick C J Virol; 2019 Nov; 93(21):. PubMed ID: 31375594 [TBL] [Abstract][Full Text] [Related]
16. Potent antiviral activity of north-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus. Zhu W; Burnette A; Dorjsuren D; Roberts PE; Huleihel M; Shoemaker RH; Marquez VE; Agbaria R; Sei S Antimicrob Agents Chemother; 2005 Dec; 49(12):4965-73. PubMed ID: 16304159 [TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. Xu B; Wang L; González-Molleda L; Wang Y; Xu J; Yuan Y Antimicrob Agents Chemother; 2014; 58(1):563-73. PubMed ID: 24295975 [TBL] [Abstract][Full Text] [Related]
18. Chloroquine inhibits lytic replication of Kaposi's sarcoma-associated herpesvirus by disrupting mTOR and p38-MAPK activation. Yang M; Huang L; Li X; Kuang E Antiviral Res; 2016 Sep; 133():223-33. PubMed ID: 27521848 [TBL] [Abstract][Full Text] [Related]
19. Lytic induction of Kaposi's sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening. Cho HJ; Yu F; Sun R; Lee D; Song MJ Arch Virol; 2008; 153(8):1517-25. PubMed ID: 18607675 [TBL] [Abstract][Full Text] [Related]
20. Genipin Enhances Kaposi's Sarcoma-Associated Herpesvirus Genome Maintenance. Cho M; Jung SW; Lee S; Son K; Park GH; Jung JW; Shin YS; Seo T; Hyosun Cho ; Kang H PLoS One; 2016; 11(10):e0163693. PubMed ID: 27736870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]